perfosfamide has been researched along with Brain Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antao, N; Cohn, SL; Cox, NJ; Diskin, SJ; Dolan, ME; Gamazon, ER; Im, HK; Konkashbaev, A; London, WB; Ludeman, SM; Maris, JM; Myers, J; Pinto, N; Stark, AL | 1 |
| Dörken, B; Fliedner, TM; Ho, AD; Hunstein, W; Körbling, M; Tischbirek, K; Zipperle, G | 1 |
| Brem, H; Buahin, KG; Colvin, OM; Domb, A; Epstein, JI; Judy, KD; Olivi, A | 1 |
| Aaron, RH; Bigner, DD; Colvin, OM; Elion, GB; Friedman, HS; Graham, M; Keir, S | 1 |
| Archer, GE; Bigner, DD; Colvin, OM; Friedman, HS; Fuchs, HE; McLendon, RE; Schuster, JM | 1 |
| Brem, H; Buahin, KG | 1 |
| Baraban, J; Brem, H; Burger, PC; Li, KW; Piantadosi, S; Ratan, R; Sipos, EP; Witham, TF | 1 |
| Affronti, ML; Bast, RC; Eggleston, S; Johnston, C; Jones, RB; Rosner, GL; Ross, M; Shpall, EJ; Tepperburg, M; Vandermark, R | 1 |
1 trial(s) available for perfosfamide and Brain Neoplasms
| Article | Year |
|---|---|
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplastic Stem Cells; Survival Rate | 1991 |
7 other study(ies) available for perfosfamide and Brain Neoplasms
| Article | Year |
|---|---|
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Child; Cohort Studies; Cyclohexylamines; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Neoplasm; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Humans; Neuroblastoma; Phenotype; Polymorphism, Single Nucleotide; Quality Control; Real-Time Polymerase Chain Reaction; Risk Assessment; RNA, Small Interfering; Treatment Failure | 2014 |
Autologous transplantation of a bone marrow graft manipulated by chemoseparation to eliminate residual tumor cells.
Topics: Bone Marrow; Bone Marrow Transplantation; Brain Neoplasms; Cyclophosphamide; Freezing; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Tissue Preservation; Transplantation, Autologous | 1983 |
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cyclophosphamide; Decanoic Acids; Delayed-Action Preparations; Dicarboxylic Acids; Drug Implants; Erucic Acids; Glioma; Male; Neoplasm Transplantation; Polymers; Rats; Rats, Inbred F344; Survival Rate; Tumor Cells, Cultured | 1995 |
Busulfan therapy of central nervous system xenografts in athymic mice.
Topics: Animals; Brain Neoplasms; Busulfan; Child, Preschool; Cyclophosphamide; Female; Humans; Injections, Intraperitoneal; Male; Medulloblastoma; Melphalan; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
Topics: Animals; Body Weight; Brain Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Glioma; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Mice; Mice, Nude; Rats; Rats, Nude; Transplantation, Heterologous | 1993 |
Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Transplantation; Cyclophosphamide; Delayed-Action Preparations; Gliosarcoma; Injections; Male; Neoplasm Transplantation; Polymers; Rats; Rats, Inbred F344 | 1995 |
L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Brain; Brain Neoplasms; Buthionine Sulfoximine; Cyclophosphamide; Drug Combinations; Drug Implants; Drug Synergism; Glioma; Glutathione; Injections, Intraperitoneal; Liver; Male; Rats; Rats, Inbred F344; Reference Values; Survival Analysis | 2001 |